Last reviewed · How we verify
Silvadene® Cream 1% [Silver Sulfadiazine] — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Silvadene® Cream 1% [Silver Sulfadiazine] (Silvadene® Cream 1% [Silver Sulfadiazine]) — Skingenix, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Silvadene® Cream 1% [Silver Sulfadiazine] TARGET | Silvadene® Cream 1% [Silver Sulfadiazine] | Skingenix, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Silvadene® Cream 1% [Silver Sulfadiazine] CI watch — RSS
- Silvadene® Cream 1% [Silver Sulfadiazine] CI watch — Atom
- Silvadene® Cream 1% [Silver Sulfadiazine] CI watch — JSON
- Silvadene® Cream 1% [Silver Sulfadiazine] alone — RSS
Cite this brief
Drug Landscape (2026). Silvadene® Cream 1% [Silver Sulfadiazine] — Competitive Intelligence Brief. https://druglandscape.com/ci/silvadene-cream-1-silver-sulfadiazine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab